Results 281 to 290 of about 144,316 (318)
Some of the next articles are maybe not open access.
Clinical and Translational Oncology, 2007
Anaemia is a frequent complication in cancer patients and may be multifactorial in origin. Treatment with recombinant human erythropoietin (rHuEPO) is an alternative to red blood cell transfusion. The evidence from clinical trials has established that patients with chemotherapy-induced anaemia with a haemoglobin concentration below 10 g/dl benefit from
J M, Jurado García +3 more
openaire +2 more sources
Anaemia is a frequent complication in cancer patients and may be multifactorial in origin. Treatment with recombinant human erythropoietin (rHuEPO) is an alternative to red blood cell transfusion. The evidence from clinical trials has established that patients with chemotherapy-induced anaemia with a haemoglobin concentration below 10 g/dl benefit from
J M, Jurado García +3 more
openaire +2 more sources
Nursing Standard, 1991
Withdrawal of erythropoietin from patients undergoing dialysis might precipitate a rebound of physical and psychological morbidity, researchers say.
openaire +2 more sources
Withdrawal of erythropoietin from patients undergoing dialysis might precipitate a rebound of physical and psychological morbidity, researchers say.
openaire +2 more sources
2009
Erythropoietin (EPO), a glycoprotein hormone, stimulates the growth of red blood cells and as a consequence it increases tissue oxygenation. This performance enhancing effect is responsible for the ban of erythropioetin in sports since 1990. Especially its recombinant synthesis led to the abuse of this hormone, predominatly in endurance sports.
Christian, Reichel, Günter, Gmeiner
openaire +2 more sources
Erythropoietin (EPO), a glycoprotein hormone, stimulates the growth of red blood cells and as a consequence it increases tissue oxygenation. This performance enhancing effect is responsible for the ban of erythropioetin in sports since 1990. Especially its recombinant synthesis led to the abuse of this hormone, predominatly in endurance sports.
Christian, Reichel, Günter, Gmeiner
openaire +2 more sources
2017
We sought to briefly describe current models of endogenous erythropoietin (EPO) pleiotropic properties to make four points clear. First, endogenous EPO regulates erythroid cell apoptosis so that red blood cell production is balanced against the number of cells destroyed in order to maintain optimal tissue oxygen levels (i.e., consistent with provision ...
Steven J, Korzeniewski, Athina, Pappas
openaire +2 more sources
We sought to briefly describe current models of endogenous erythropoietin (EPO) pleiotropic properties to make four points clear. First, endogenous EPO regulates erythroid cell apoptosis so that red blood cell production is balanced against the number of cells destroyed in order to maintain optimal tissue oxygen levels (i.e., consistent with provision ...
Steven J, Korzeniewski, Athina, Pappas
openaire +2 more sources
The transcriptional and regulatory identity of erythropoietin producing cells
Nature Medicine, 2023Bjørt K Kragesteen, , Baoguo Li
exaly